Clinical Trial Update: RIBOGENE: Optimisation of Riboflavin Status in Hypertensive Adults With a Genetic Predisposition to Elevated Blood Pressure [NA]

View source ↗

Summary

This clinical trial update describes a University of Ulster study (RIBOGENE) aimed at optimizing riboflavin status in hypertensive adults with the MTHFR 677TT g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• RIBOGENE (riboflavin)

Snippet

Sponsor: University of Ulster | Conditions: Participants With the MTHFR 677TT Genotype | NA | Status: UNKNOWN